<VariationArchive RecordType="classified" VariationID="521127" VariationName="NM_003106.4(SOX2):c.70_86del (p.Asn24fs)" VariationType="Deletion" Accession="VCV000521127" Version="4" NumberOfSubmissions="2" NumberOfSubmitters="2" DateLastUpdated="2023-03-26" DateCreated="2018-04-15" MostRecentSubmission="2023-01-07">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="511470" VariationID="521127">
      <GeneList>
        <Gene Symbol="LOC108281177" FullName="SOX2 5' regulatory region" GeneID="108281177" Source="calculated" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>3q26.33</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="3" Accession="NC_000003.12" start="181707848" stop="181712914" display_start="181707848" display_stop="181712914" Strand="+" />
          </Location>
        </Gene>
        <Gene Symbol="SOX2" FullName="SRY-box transcription factor 2" GeneID="6657" HGNC_ID="HGNC:11195" Source="submitted" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>3q26.33</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="3" Accession="NC_000003.12" start="181711925" stop="181714436" display_start="181711925" display_stop="181714436" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="3" Accession="NC_000003.11" start="181429711" stop="181432223" display_start="181429711" display_stop="181432223" Strand="+" />
          </Location>
          <OMIM>184429</OMIM>
          <Haploinsufficiency last_evaluated="2012-07-06" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=SOX2">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2012-07-06" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=SOX2">No evidence available</Triplosensitivity>
        </Gene>
        <Gene Symbol="SOX2-OT" FullName="SOX2 overlapping transcript" GeneID="347689" HGNC_ID="HGNC:20209" Source="calculated" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>3q26.33</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="3" Accession="NC_000003.12" start="181056680" stop="181742228" display_start="181056680" display_stop="181742228" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="3" Accession="NC_000003.11" start="181328150" stop="181459008" display_start="181328150" display_stop="181459008" Strand="+" />
          </Location>
          <OMIM>616338</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_003106.4(SOX2):c.70_86del (p.Asn24fs)</Name>
      <CanonicalSPDI>NC_000003.12:181712421:GCGGCGGCAACTCCACCGCGGCGGC:GCGGCGGC</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>3q26.33</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="3" Accession="NC_000003.12" start="181712422" stop="181712438" display_start="181712422" display_stop="181712438" variantLength="17" positionVCF="181712421" referenceAlleleVCF="GGCGGCGGCAACTCCACC" alternateAlleleVCF="G" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="3" Accession="NC_000003.11" start="181430210" stop="181430226" display_start="181430210" display_stop="181430226" variantLength="17" positionVCF="181430209" referenceAlleleVCF="GGCGGCGGCAACTCCACC" alternateAlleleVCF="G" />
      </Location>
      <ProteinChange>N24fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000003.11" sequenceAccession="NC_000003" sequenceVersion="11" change="g.181430218_181430234del" Assembly="GRCh37">
            <Expression>NC_000003.11:g.181430218_181430234del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000003.12" sequenceAccession="NC_000003" sequenceVersion="12" change="g.181712430_181712446del" Assembly="GRCh38">
            <Expression>NC_000003.12:g.181712430_181712446del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_009080.1" sequenceAccession="NG_009080" sequenceVersion="1" change="g.5497_5513del">
            <Expression>NG_009080.1:g.5497_5513del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_003106.4" sequenceAccession="NM_003106" sequenceVersion="4" change="c.70_86del" MANESelect="true">
            <Expression>NM_003106.4:c.70_86del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_003097.1" sequenceAccession="NP_003097" sequenceVersion="1" change="p.Asn24fs">
            <Expression>NP_003097.1:p.Asn24fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_719" sequenceAccession="LRG_719" change="g.5497_5513del">
            <Expression>LRG_719:g.5497_5513del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA658796398" DB="ClinGen" />
        <XRef Type="Allelic variant" ID="184429.0014" DB="OMIM" />
        <XRef Type="rs" ID="1553862927" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_003106.4(SOX2):c.70_86del (p.Asn24fs) AND Inborn genetic diseases" Accession="RCV000622595" Version="2">
        <ClassifiedConditionList TraitSetID="25797">
          <ClassifiedCondition DB="MedGen" ID="C0950123">Inborn genetic diseases</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2016-06-14" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_003106.4(SOX2):c.70_86del (p.Asn24fs) AND Anophthalmia/microphthalmia-esophageal atresia syndrome" Accession="RCV002307563" Version="1">
        <ClassifiedConditionList TraitSetID="3485">
          <ClassifiedCondition DB="MedGen" ID="C1859773">Anophthalmia/microphthalmia-esophageal atresia syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2007-02-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2016-06-14" NumberOfSubmissions="2" NumberOfSubmitters="2" DateCreated="2018-04-15" MostRecentSubmission="2023-01-07">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">12002146</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">17219395</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">24804704</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="25797" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="32761" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Inborn genetic diseases</ElementValue>
              </Name>
              <Citation Type="general" Abbrev="Langer et al., 2012">
                <ID Source="PubMed">22947299</ID>
              </Citation>
              <Citation Type="general" Abbrev="SACHDNC, 2013">
                <ID Source="PubMed">23037933</ID>
              </Citation>
              <Citation Type="general" Abbrev="EASAC/FEAM, 2013">
                <ID Source="PubMed">23169492</ID>
              </Citation>
              <Citation Type="general" Abbrev="ESHG/P3G/HUGO/PHGF, 2015">
                <ID Source="PubMed">25626707</ID>
              </Citation>
              <Citation Type="general" Abbrev="Alpha-1 Foundation, 2014">
                <ID Source="PubMed">24121147</ID>
              </Citation>
              <Citation Type="general" Abbrev="NBSTRN, 2015">
                <ID Source="PubMed">24394680</ID>
              </Citation>
              <Citation Type="general" Abbrev="EUNENBS, 2014">
                <ID Source="PubMed">23652378</ID>
              </Citation>
              <Citation Type="general" Abbrev="NSGC, 2014">
                <ID Source="PubMed">23881473</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG/ACOG/NSGC/PQF/SMFM, 2015">
                <ID Source="PubMed">25730230</ID>
              </Citation>
              <Citation Type="general" Abbrev="Skirton et al., 2014">
                <ID Source="PubMed">24022298</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2013">
                <ID Source="PubMed">23619275</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACOG, 2019">
                <ID Source="PubMed">31022120</ID>
              </Citation>
              <XRef ID="C0950123" DB="MedGen" />
              <XRef ID="D030342" DB="MeSH" />
            </Trait>
          </TraitSet>
          <TraitSet ID="3485" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="5530" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Microphthalmia syndromic 3</ElementValue>
                <XRef ID="Microphthalmia+syndromic+3/4787" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Anophthalmia/microphthalmia-esophageal atresia syndrome</ElementValue>
                <XRef ID="MONDO:0008799" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Microphthalmia and esophageal atresia syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Anophthalmia clinical with associated anomalies</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Anophthalmia esophageal genital syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">AEG syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Anophthalmia microphthalmia esophageal atresia</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">MCOPS3</ElementValue>
                <XRef Type="MIM" ID="206900" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="keyword">SOX2-Related Eye Disorders</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">SOX2 Disorder</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">The phenotypic spectrum of SOX2 disorder includes anophthalmia and/or microphthalmia, brain malformations, developmental delayÂ / intellectual disability, esophageal atresia, hypogonadotropic hypogonadism (manifest as cryptorchidism and micropenis in males, gonadal dysgenesis infrequently in females, and delayed puberty in both sexes), pituitary hypoplasia, postnatal growth delay, hypotonia, seizures, and spastic or dystonic movements.</Attribute>
                <XRef ID="NBK1300" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="1443" />
                <XRef ID="1443" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">SOX2 anophthalmia syndrome</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">SOX2-related eye disorders</Attribute>
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301477</ID>
                <ID Source="BookShelf">NBK1300</ID>
              </Citation>
              <XRef ID="77298" DB="Orphanet" />
              <XRef ID="C1859773" DB="MedGen" />
              <XRef ID="MONDO:0008799" DB="MONDO" />
              <XRef Type="MIM" ID="206900" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="33922" SubmissionDate="2018-01-19" DateLastUpdated="2018-01-23" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="184429.0014_MICROPHTHALMIA, SYNDROMIC 3" title="SOX2, 17-BP DEL, NT70_MICROPHTHALMIA, SYNDROMIC 3" />
        <ClinVarAccession Accession="SCV000033922" DateUpdated="2018-01-23" DateCreated="2013-04-04" Type="SCV" Version="3" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2007-02-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In 2 female sibs with syndromid microphthalmia (MCOPS3; 206900), 1 of whom was previously reported by Menetrey et al. (2002), Chassaing et al. (2007) identified heterozygosity for a 17-bp deletion (70del17) in the SOX2 gene, predicted to cause a frameshift resulting in a premature termination signal at codon 66. The first sib had bilateral anophthalmia and esophageal atresia. During the mother's subsequent pregnancy, the fetus showed severe and progressive triventricular hydrocephalus on ultrasound, and the pregnancy was interrupted. Autopsy showed stenosis of the Sylvian aqueduct, and hypoplasia of the corpus callosum, but age-appropriate ocular length and normal external and microscopic ocular examination. The mother was found to have germinal mosaicism for the mutation, estimated at approximately 3%.</Attribute>
              <Citation>
                <ID Source="PubMed">12002146</ID>
              </Citation>
              <Citation>
                <ID Source="PubMed">17219395</ID>
              </Citation>
              <XRef DB="OMIM" ID="206900" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SOX2" />
          </GeneList>
          <Name>SOX2, 17-BP DEL, NT70</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">17-BP DEL, NT70</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="184429.0014" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">MICROPHTHALMIA, SYNDROMIC 3</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1445364" SubmissionDate="2020-10-09" DateLastUpdated="2023-01-07" DateCreated="2018-04-15">
        <ClinVarSubmissionID localKey="a399829" localKeyIsSubmitted="1" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000741572" DateUpdated="2023-01-07" DateCreated="2018-04-15" Type="SCV" Version="3" SubmitterName="Ambry Genetics" OrgID="61756" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2016-06-14">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">17219395</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">24804704</ID>
          </Citation>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Ambry exome assertion method (8-5-2015)</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/xlwdlsvu/ambry_exome_assertion_method_8-5-2015_.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Ethnicity>Caucasian</Ethnicity>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
              <NumberTested>1</NumberTested>
              <Gender>male</Gender>
              <FamilyData PedigreeID="a984712" />
              <Proband>yes</Proband>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
            <TraitSet Type="Finding">
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <Name>
                  <ElementValue Type="Preferred">Anophthalmia</ElementValue>
                </Name>
                <XRef DB="HP" ID="HP:0000528" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <Name>
                  <ElementValue Type="Preferred">Congenital cataract</ElementValue>
                </Name>
                <XRef DB="HP" ID="HP:0000519" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <Name>
                  <ElementValue Type="Preferred">Cataract (disease)</ElementValue>
                </Name>
                <XRef DB="HP" ID="HP:0000518" />
              </Trait>
            </TraitSet>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SOX2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_003106.3:c.70_86del17</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MeSH" ID="D030342" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>NovelandUpdateExomeDeposit_ExomeProgenyThrough080120</SubmissionName>
          <SubmissionName>exome clinvar deposit 2.18.18</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="33922" TraitType="Disease" MappingType="Name" MappingValue="MICROPHTHALMIA, SYNDROMIC 3" MappingRef="Preferred">
        <MedGen CUI="C1859773" Name="Anophthalmia/microphthalmia-esophageal atresia syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1445364" TraitType="Finding" MappingType="Name" MappingValue="Cataract (disease)" MappingRef="Preferred">
        <MedGen CUI="C0086543" Name="Cataract" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1445364" TraitType="Finding" MappingType="Name" MappingValue="Anophthalmia" MappingRef="Preferred">
        <MedGen CUI="C0003119" Name="Anophthalmia" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1445364" TraitType="Disease" MappingType="XRef" MappingValue="D030342" MappingRef="MeSH">
        <MedGen CUI="C0950123" Name="Inborn genetic diseases" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1445364" TraitType="Finding" MappingType="Name" MappingValue="Congenital cataract" MappingRef="Preferred">
        <MedGen CUI="C0009691" Name="Developmental cataract" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

